Literature DB >> 16718824

Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma.

Ze-Yu Wu1, Jing-Hua Li, Wen-Hua Zhan, Yu-Long He.   

Abstract

AIM: To examine matrix metalloproteinase-2 (MMP-2) expression in gastric cancer tissues and to evaluate its relationship with lymph node micrometastasis.
METHODS: The authors studied 850 lymph nodes resected from 30 patients with gastric carcinoma who underwent gastrectomy with lymphadenectomy using reverse transcription polymerase chain reaction (RT-PCR) assay in addition to H-E staining. MMP-2 expression of the tumor tissues was detected by immunohistochemical technique (EliVision plus).
RESULTS: MMP-2 expression was positive in 21 (70%) cases and negative in 9 (30%) cases. No significant correlations were found between MMP-2 expression and other variables such as age, gender, tumor location, tumor diameter, Lauren classification and lymphatic invasion. In contrast, MMP-2 expression correlated significantly with depth of tumor infiltration (P = 0.022), lymph node metastasis (P = 0.030) and tumor differentiation (P = 0.043). Lymph node micrometastases were detected in 77 (12.5%) lymph nodes of 14 (46.7%) gastric carcinoma patients. MMP-2 expression was positive in 12 (85.7%) of the 14 patients with lymph node micrometastasis, and in 9 (56.3%) of the 16 patients without lymph node micrometastasis (P = 0.118).
CONCLUSION: Our results demonstrate that MMP-2 expression has significant correlation with tumor invasion, tumor differentiation and lymph node metastases. MMP-2 expression may be an important biological characteristics and significant prognostic parameter of gastric carcinoma. We also conclude that MMP-2 may participate in the development of lymph node micrometastasis of gastric carcinoma. Further investigations are needed to draw a conclusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718824      PMCID: PMC4087816          DOI: 10.3748/wjg.v12.i18.2941

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.

Authors:  L Saragoni; M Gaudio; P Morgagni; S Folli; F Bazzocchi; E Scarpi; A Saragoni
Journal:  Oncol Rep       Date:  2000 May-Jun       Impact factor: 3.906

2.  [MMP-2 expression (type IV collagenase) in gastric cancer].

Authors:  A Sundblad; L Ricci
Journal:  Acta Gastroenterol Latinoam       Date:  1998

3.  Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma.

Authors:  Hong-Jo Choi; Yun-Ki Kim; Young-Hoon Kim; Sang-Soon Kim; Sook-Hee Hong
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

4.  Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay.

Authors:  Y Okada; Y Fujiwara; H Yamamoto; Y Sugita; T Yasuda; Y Doki; S Tamura; M Yano; H Shiozaki; N Matsuura; M Monden
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

5.  Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer.

Authors:  A Nakajo; S Natsugoe; S Ishigami; M Matsumoto; S Nakashima; S Hokita; M Baba; S Takao; T Aikou
Journal:  Ann Surg Oncol       Date:  2001-03       Impact factor: 5.344

6.  Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer.

Authors:  Jianhui Cai; Masahide Ikeguchi; Michio Maeta; Nobuaki Kaibara; Takashi Sakatani
Journal:  Gastric Cancer       Date:  1999-08       Impact factor: 7.370

7.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

8.  Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion.

Authors:  Hiroshi Higashi; Shoji Natsugoe; Sumiya Ishigami; Yoshikazu Uenosono; Masataka Matsumoto; Akihiro Nakajo; Futoshi Miyazono; Shuichi Hokita; Sonshin Takao; Takashi Aikou
Journal:  World J Surg       Date:  2003-04       Impact factor: 3.352

9.  Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma.

Authors:  Yutaka Takahashi; Yasuhiko Kitadai; Lee M Ellis; Corazon D Bucana; Isaiah J Fidler; Masayoshi Mai
Journal:  Jpn J Cancer Res       Date:  2002-11

10.  Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.

Authors:  S L Parsons; S A Watson; H M Collins; N R Griffin; P A Clarke; R J Steele
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  11 in total

1.  Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer.

Authors:  Lin-Bo Wang; Zhi-Nong Jiang; Miao-Ying Fan; Chao-Yang Xu; Wen-Jun Chen; Jian-Guo Shen
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 2.  The evolution of imaging in cancer: current state and future challenges.

Authors:  Luke J Higgins; Martin G Pomper
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

3.  Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.

Authors:  Daniel Cordeiro Gurgel; José Telmo Valença-Junior; Conceição Aparecida Dornelas; Renato Braga Vieira; João Tarcisio Alves Maia-Filho; Roberto Cesar Pereira Lima-Junior; Ronaldo Albuquerque Ribeiro; Paulo Roberto Carvalho Almeida
Journal:  Pathol Oncol Res       Date:  2014-05-07       Impact factor: 3.201

4.  Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Chong-Yang Cai; Yang Wu; Zhi-Gang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells.

Authors:  Wei Huang; Li-Fen Yu; Jie Zhong; Wei Wu; Jia-Ying Zhu; Feng-Xiang Jiang; Yun-Lin Wu
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

6.  Effect of lymph node micrometastases on prognosis of gastric carcinoma.

Authors:  Ze-Yu Wu; Jing-Hua Li; Wen-Hua Zhan; Yu-Long He; Jin Wan
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

7.  Inhibitory effect of siRNA-Annexin A7 on growth, migration, and invasion in BGC823 cells and gastric cancer xenograftsin nude mice.

Authors:  Hu-Fang Yuan; Yong Li; Bi-Bo Tan; Qun Zhao; Li-Qiao Fan; Zhao-Jie An
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

8.  Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations.

Authors:  Elham Jafari; Somaye Safinejad; Shahriar Dabiri; Ahmad Naghibzadeh-Tahami
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

9.  Aquaporin-3 positively regulates matrix metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells.

Authors:  Hao Xu; Yong Xu; Wenjie Zhang; Lizong Shen; Li Yang; Zekuan Xu
Journal:  J Exp Clin Cancer Res       Date:  2011-09-25

10.  Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.

Authors:  H Q Xi; A Z Cai; X S Wu; J X Cui; W S Shen; S B Bian; N Wang; J Y Li; C R Lu; Z Song; B Wei; L Chen
Journal:  Br J Cancer       Date:  2014-03-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.